Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000788

Director sold 55,569 shares at an average $19.59 ($1,088,561)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-14 Sale : show line 1 in the form −29,983 $19.64 $588,866 2,143,017 I
2017-08-15 Sale : show line 2 in the form −25,586 $19.53 $499,695 2,117,431 I
Open-market sales · 55,569 sh · avg $19.59 · $1,088,561
Loading xslF345X03/vonemster_fm4aug142017.xml…